Resistance in Enterococcus faecium to the glycopeptide antibiotics vancomycin and teicoplanin is encoded by five genes: vanR, vanS, vanH, vanA, and vanX.1 The mechanism of resistance involves replacement of the dipeptide D-Ala-D-Ala, destined for the peptidoglycan layer with the depsipeptide D-Ala-D-lactate. This alteration lowers the binding affinity of vancomycin for the bacterial cell wall by a factor of 1000. The functions of VanA and VanX are the ligation of D-Ala and D-lactate, and the hydrolysis of D-Ala-D-Ala, respectively. We report here the overexpression of both genes as well as the D-Ala-D-Ala ligase (Ddl) from Enterococcus faecium, development of a coupled assay and several inhibitors obtained by high-throughput screening (HTS). All genes were expressed in E. coli by translational coupling to kdsB, the CMP-KDO synthetase gene, under control of a modified lac promoter. The coupled VanA/VanX assay employs colorimetric detection of inorganic phosphate (Pi) released in the VanA ligation reaction, with the VanX dipeptidase activity providing the D-Ala substrate for VanA. A secondary VanX assay uses cadmium-ninhydrin calorimetric detection of free amino acid released by the dipeptidase activity of the enzyme on D-Ala-D-Ala. We have also developed an assay using Ddl ligase. Over 250,000 compounds have been screened to date using the coupled assay.
References
1.
Arthur, M., Molinas, C., Depardieu, F., Courvalin, P. (1993). Characterization of TnJ546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol.175:117.
2.
Barna, J.C.J., Williams, D.H. (1984). The structure and mode of action of glycopeptide antibiotics of the vancomycin group. Ann. Rev. Microbiol.38:339.
3.
Leclercq, R., Derlot, E., Duval, J., Courvalin, P. (1988). Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med.319:157.
4.
Leclercq, R., Derlot, E., Weber, J., Duval, J., Courvalin, P. (1989). Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob. Agents Chemother.33:10.
5.
al-Obeid, S., Gutmann, L., Shlaes, D., Williamson, R., Collatz, E. (1990). Comparison of vancomycin-inducible proteins from four strains of Enterococci. FEMS Microbiol. Lett.70:101.
6.
Walsh, C.T., Fisher, S.L., Park, I-S., Prahalad, M., Wu, Z. (1996). Bacterial resistance to vancomycin: Five genes and one missing hydrogen bond tell the story. Current Biology3:21.
7.
Bolling, T.J., Mandecki, W. (1990). An Escherichia coli expression vector for high-level production of heterologous proteins in fusion with CMP-KDO synthetase. BioTechniques8:488.
8.
Bugg, T., Dutka-Malen, S., Arthur, M., Courvalin, P., Walsh, C. (1991). Identification of vancomycin resistance protein VanA as a D-Alanine: D-Alanine ligase of altered substrate specificity. Biochemistry30:2017.
9.
Wu, Z., Wright, G., Walsh, C. (1995). Overexpression, purification, and characterization of VanX, a D-,D-Dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry34:2455.
10.
Daub, E., Zawadzke, L., Botstein, D., Walsh, C. (1988). Isolation, cloning, and sequencing of the Salmonella typhimurium ddlA gene with purification and characterization of its product, D-Alanine:D-Alanine ligase. Biochemistry27:701.
11.
Burres, N.S. (1996). Mixing strategies for efficient high-through-put screening. In Cost-effective strategies for automated and accelerated high-throughput screening. In K. Emory, J. Schlegel (eds.), pp. 1.1.1-1.1.16. IBC Inc., Southborough, MA.
12.
Woodford, N., Johnson, A.P., Morrison, D., Speller, D.C.E. (1995). Current perspectives on glycopeptide resistance. Clin. Microbiol. Rev.8:585.
13.
Pilot-Matias, T.J., Pratt, S.D., Lane, B.C. (1993). High-level synthesis of the 12-kDa human FK506-binding protein in Escherichia coli using translational coupling. Gene128:219.
